Preproinsulin-specific CD8+ T cells secrete IFNgamma in human type 1 diabetes.
Standard
Preproinsulin-specific CD8+ T cells secrete IFNgamma in human type 1 diabetes. / Rathmann, Silvia; Rajasalu, Tarvo; Rosinger, Silke; Schlosser, Michael; Eiermann, Thomas; Boehm, Bernhard O; Durinovic-Belló, Ivana.
in: ANN NY ACAD SCI, Jahrgang 1037, 2004, S. 22-25.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Preproinsulin-specific CD8+ T cells secrete IFNgamma in human type 1 diabetes.
AU - Rathmann, Silvia
AU - Rajasalu, Tarvo
AU - Rosinger, Silke
AU - Schlosser, Michael
AU - Eiermann, Thomas
AU - Boehm, Bernhard O
AU - Durinovic-Belló, Ivana
PY - 2004
Y1 - 2004
N2 - In animal models autoreactive CD8(+) T cells are crucial in the development of type 1 diabetes (T1D); however, their role in human T1D is still not known. To address the role of CD81 T cells we performed a pilot study by investigating CD8(+) T cell-mediated cytokine secretion after in vitro stimulation with 94 preproinsulin (PPI) peptides. We were able to show that CD8(+) T cells contribute to a strong IFNgamma reactivity against PPI in human T1D. Further investigations defining epitope specificity, cytokine secretion, and cytotoxic capacity are important to clarify their role in T1D development.
AB - In animal models autoreactive CD8(+) T cells are crucial in the development of type 1 diabetes (T1D); however, their role in human T1D is still not known. To address the role of CD81 T cells we performed a pilot study by investigating CD8(+) T cell-mediated cytokine secretion after in vitro stimulation with 94 preproinsulin (PPI) peptides. We were able to show that CD8(+) T cells contribute to a strong IFNgamma reactivity against PPI in human T1D. Further investigations defining epitope specificity, cytokine secretion, and cytotoxic capacity are important to clarify their role in T1D development.
M3 - SCORING: Zeitschriftenaufsatz
VL - 1037
SP - 22
EP - 25
JO - ANN NY ACAD SCI
JF - ANN NY ACAD SCI
SN - 0077-8923
ER -